STELLA THERAPEUTICS
Stella Therapeutics is developing novel small molecules (ST drugs) that hold the promise of treating malignant tumors through a unique mechanism of action by initially blocking the migration and proliferation of tumor cells, and then selectively killing them through the induction of apoptosis (programmed cell death).
STELLA THERAPEUTICS
Industry:
Biotechnology Internet Medical Pharmaceutical
Founded:
2013-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.stellatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
2067261217
Technology used in webpage:
Amazon Amazon Virginia Region
Similar Organizations
DS Biopharma
DS Biopharma is a privately held drug discovery and development company.
Enantigen Therapeutics
Enantigen Therapeutics, Inc. is a privately-held pharmaceutical company.
Global Genomics Capital
Global Genomics Capital is a privately held genomics company.
Quanticel Pharmaceuticals
Quanticel Pharmaceuticals is a privately held drug discovery company
Small Molecule Therapeutics
Small Molecule Therapeutics operates as a drug discovery company.
Official Site Inspections
http://www.stellatherapeutics.com
Unable to get host informations!!!
More informations about "Stella Therapeutics"
Stella Therapeutics - Crunchbase Company Profile & Funding
Stella Therapeutics, a privately held drug discovery company. Stella Therapeutics is developing novel small molecules (ST drugs) that hold the promise of treating malignant tumors through a …See details»
STELLA THERAPEUTICS, INC - VentureRadar
Dec 31, 2016 Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»
Stella Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Stella Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:GPR124 agonists (Stella Therapeutics).See details»
Stella Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Stella Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Drug:GPR124 agonists (Stella Therapeutics). Biomedical products. Data. ... The …See details»
Stella Therapeutics | Seattle, WA, USA Startup - Gust
Mar 1, 2011 Mr. Howse has been a longtime adviser to Stella Therapeutics and joined the board in 2012. He is currently a Director at Capstone Therapeutics, and was the President and Co …See details»
Stella Therapeutics - Products, Competitors, Financials, Employees ...
Stella Therapeutics, a privately held drug discovery company, is developing first-in-class small molecules that hold the promise of curing Glioblastoma Multiforme (GBM), the most common …See details»
Home - ShapeTX
We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Shape TX combines …See details»
Stella Therapeutics - CoMotion
Jan 1, 2013 Stella Therapeutics, a privately held drug discovery company, is developing first-in-class small molecules that hold the promise of curing Glioblastoma Multiforme (GBM), the …See details»
Stella Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Stella Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. About. Stella …See details»
Stella Therapeutics Culture | Comparably
Learn about Stella Therapeutics' culture, see what work's like, read reviews, and find job opportunities.See details»
Stella Opens Flagship PTSD Treatment Location in Chicago
May 9, 2023 Funds raised from Sterling Partners will be used to further innovative research and expand access to cutting-edge care. May 09, 2023 09:00 ET | Source: StellaSee details»
Stellate Therapeutics - Crunchbase Company Profile & Funding
Stellate Therapeutics is a private global biotechnology company that develops small molecules produced by human gut bacteria into first-in-class personalized therapies for neurological …See details»
Pipeline overview | Omega Therapeutics development candidates
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. You can allow the use of all cookies by clicking “Accept All”.If …See details»
Mestag Therapeutics » Signaling a new era in immunotherapy
Urgently advancing first-in-class antibodies to clinic. Activated fibroblasts play an important and often overlooked role in driving the immune system’s response in cancer and inflammatory …See details»
Compass Therapeutics
We are developing next generation antibodies into transformative cancer therapies that improve patients’ lives. We’re leveraging our understanding of the tumor microenvironment to develop …See details»
Antibiotics | OSTA Therapeutics
World Health Organization. Learn More ©2024 par Osta Therapeutics. bottom of page ...See details»
Intellia Therapeutics - Revolutionize the course of medicine
Intellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.See details»
Nanoscope Therapeutics
Nanoscope is focused on proprietary ambient light activated optogenetic therapy to restore vision in people suffering from all forms of Retinitis Pigmentosa, Stargardt and other inherited retinal …See details»
Home - Fate Therapeutics
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you …See details»
Houston biotech company developing multiple Treg-based therapies
Nov 25, 2024 We are a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells. We are currently developing our …See details»